Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review

During the course of treating non-small cell lung cancer (NSCLC) with epithelial growth factor receptor (EGFR) mutant, gefitinib resistance (GR) is unavoidable. As the environment for tumor cells to grow and survive, tumor microenvironment (TME) can significantly affect therapeutic response and clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mu-Tong, Li, Bai-Zhi, Zhang, En-Pu, Zheng, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553124/
https://www.ncbi.nlm.nih.gov/pubmed/37800802
http://dx.doi.org/10.1097/MD.0000000000035086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553124/
https://www.ncbi.nlm.nih.gov/pubmed/37800802
http://dx.doi.org/10.1097/MD.0000000000035086

Ejemplares similares